학술논문
A multicenter, open-label, uncontrolled, single-arm phase 2 study of tirabrutinib, an oral Bruton’s tyrosine kinase inhibitor, in pemphigus
Document Type
Article
Author
Source
In Journal of Dermatological Science September 2021 103(3):135-142
Subject
Language
ISSN
0923-1811